In June 2026, India's Central Drugs Standard Control Organisation (CDSCO) issued a directive requiring all pharmaceutical manufacturers in India to maintain a robust pharmacovigilance system for reporting adverse events (AEs)…
India's pharmaceutical export ambitions in South America are gaining fresh momentum, with both Argentina and Brazil signaling willingness to reduce trade barriers for Indian drug manufacturers, according to multiple government…
India has set ambitious goals for its pharmaceutical sector: becoming the "pharmacy of the world" for generic medicines, expanding into complex generics and biosimilars, and boosting exports to $50 billion…
On August 25, 2026, India's Central Bureau of Narcotics (CBN) and the Pharmacy Export Promotion Council of India (PHARMEXCIL) signed a Memorandum of Understanding (MoU) to strengthen regulatory oversight of…